Contact Us For Veterinairians

ONCEPT® Canine Melanoma Vaccine, DNA – Summary of Benefits

Discuss these benefits with your veterinarian.

  • Efficacy – ONCEPT is a safe, effective adjunct therapy that can significantly prolong survival times in dogs with stage II or III Canine Oral Melanoma (COM) for which local disease control has been achieved by traditional means.1
  • Safety – There are no known contraindications for the use of this product in dogs with oral melanoma. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions.2
  • Dosage – The vaccine is administered by transdermal injection in a 0.4 mL dose volume. Initial treatment requires administration of four doses of vaccine at two-week intervals. A booster dose should be administered at six-month intervals.2
  • Needle-free – The Canine Transdermal Device is especially matched to this vaccine for needle-free delivery and optimal distribution of the vaccine.